For the quarter ending 2026-03-31, HRTG had -$39,290K decrease in cash & cash equivalents over the period. $23,048K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Expected credit allowance on reinsurance | - | - | -44 | 22 |
| Net income | 36,483 | 66,675 | 50,421 | 78,498 |
| Stock-based compensation | 986 | 1,236 | 1,237 | 2,915 |
| Bond amortization and accretion | 151 | 402 | 169 | 208 |
| Gain on sale of fixed assets, net | - | - | - | 4 |
| Amortization of original issuance discount on debt | 123 | 112 | 111 | 140 |
| Depreciation and amortization | 3,152 | 3,541 | 3,302 | 5,856 |
| Allowance (recovery) for bad debt | - | - | 114 | 181 |
| Provision for credit losses | -77 | 368 | - | - |
| Net realized gains on debt securities and other investments | - | - | 2,746 | 0 |
| Net realized losses | -16 | 2,713 | - | - |
| Deferred income taxes | 1,340 | 950 | 2,364 | -939 |
| Goodwill or intangible asset impairment | - | 0 | - | - |
| Accrued investment income | -284 | 1,090 | -83 | -43 |
| Premiums receivable, net | -1,419 | 7,891 | -12,075 | -2,229 |
| Prepaid reinsurance premiums | -112,432 | -119,081 | -104,165 | 220,483 |
| Reinsurance recoverable on paid and unpaid claims | -57,409 | -60,889 | -144,612 | -216,137 |
| Income taxes receivable | - | -6,405 | -12,713 | 19,118 |
| Deferred policy acquisition costs, net | -177 | -2,248 | -4,148 | 7,736 |
| Right of use leased asset, net | 830 | -927 | -680 | -1,849 |
| Other assets | -1,244 | 379 | -3,761 | 14,539 |
| Unpaid losses and loss adjustment expenses | -35,434 | -70,107 | -63,599 | -329,504 |
| Unearned premiums | -6,833 | -25,511 | -28,801 | 59,528 |
| Debt issuance costs | - | 2 | -2,206 | - |
| Reinsurance payable | -159,303 | -146,136 | -123,343 | 275,220 |
| Accrued interest | 2 | 434 | -188 | -125 |
| Accrued compensation | -3,948 | 1,114 | 1,347 | -2,543 |
| Advance premiums | -11,633 | 7,130 | -7,688 | -3,420 |
| Leased liabilities, net | 48 | -1,022 | -716 | -1,891 |
| Income tax payable | 11,217 | 4,282 | 0 | -846 |
| Other liabilities | -6,525 | 5,450 | -2,710 | -3,973 |
| Net cash provided by operating activities | 24,864 | 13,806 | 124,303 | 44,129 |
| Fixed maturity securities sales, maturities and paydowns | 34,642 | 125,557 | 94,528 | 91,238 |
| Fixed maturity securities purchases | 77,159 | 134,538 | 123,779 | 86,327 |
| Redemption of equity securities | 0 | 0 | 0 | 893 |
| Proceeds from sale of assets | 17 | 273 | 2,895 | 16 |
| Return on other investments | 26 | 0 | 3,578 | 1,088 |
| Other investment sales | - | 0 | - | - |
| Equity securities reinvestments of dividends | 11 | 0 | 0 | 21 |
| Cost of property and equipment acquired, net of disposals | 1,816 | 2,860 | 1,583 | 3,631 |
| Net cash used in investing activities | -44,301 | -11,568 | -24,361 | 3,256 |
| Principal payments on term loan facility | 938 | 938 | 375 | 4,750 |
| Purchase of treasury stock | 10,006 | 0 | 2,283 | - |
| Proceeds from loan agreement | - | 0 | 0 | 0 |
| Repayment of loan agreement | 0 | 0 | 0 | 19,200 |
| Additional costs associated with public offering | - | - | 0 | 0 |
| Issuance of common stock, net of offering costs | - | 0 | - | - |
| Tax withholding on share-based compensation awards | 8,909 | 2,296 | - | - |
| Dividends forfeited (paid) | - | 0 | 0 | 0 |
| Mortgage loan payments | 0 | -148 | -10,491 | -148 |
| Net cash used in financing activities | -19,853 | -3,382 | -13,149 | -24,098 |
| Decrease in cash, cash equivalents, and restricted cash | -39,290 | -1,144 | 86,793 | 23,287 |
| Cash, cash equivalents and restricted cash, beginning of period | 572,581 | 573,725 | 463,645 | - |
| Cash, cash equivalents and restricted cash, end of period | 533,291 | 572,581 | 573,725 | - |